Merci au gouvernement fédéral d'avoir investi dans BioCanRx dans le cadre du Fonds scientifique stratégique. Cet investissement donne l'espoir aux patients qu'un jour nous pourrons transformer tous les cancers en maladies curables. bit.ly/3R8LW6R

An important announcement from the Government of Canada that will enable the delivery of life-saving clinical trials to cancer patients using made-in-Canada immunotherapies from @BioCanRX. TSA is very proud to support BioCanRX’s work on turning all cancers into curable diseases.

Thank you for your support throughout, Don!

Bonne année! Happy New Year from everyone at #BioCanRx!

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in phase 3 trial resulted in a significant improvement in overall survival. Learn more: pubmed.ncbi.nlm.nih.gov/37931632/ via National Library of Medicine

Informational webinar alert! Are you an Indigenous student interested in #CancerResearch? Learn about #BioCanRx’s Indigenous undergraduate summer internship program. The internship offers hands-on experience & a $9,000 award. Register to learn more: bit.ly/3HsN7JO

Are you an Indigenous undergrad student interested in a summer internship in #CancerResearch? The internship offers hands-on experience & a $9,000 award. #BioCanRx is hosting an informational webinar on Thurs. Jan. 25 at 1 pm ET. Details here: bit.ly/3HsN7JO

Are you an Indigenous undergrad student interested in a summer internship in #CancerResearch? #BioCanRx is hosting an informational webinar this Thurs. Jan. 25 at 1 pm ET. The summer internship offers hands-on experience & a $9,000 award. Details here: bit.ly/3HsN7JO

On #WorldCancerDay, and every day, the #BioCanRx network is united in closing the gap in cancer care for everyone who is diagnosed with cancer! Read a message from Scientific Director Dr. John Bell and CEO & President Dr. Stephanie Michaud: biocanrx.com/2024-world-can… #CloseTheCareGap

#BioCanRx wants to hear from you! We're asking the Canadian community engaging in, or looking to engage in, cancer #immunotherapy research to help us define our research program priorities. Please fill out our survey by Monday, April 8th: surveymonkey.com/r/NBG72SZ #CancerResearch

All cholangiocarcinoma patients deserve hope….for those with an FGF2R translocation/fusion, pemigatinib provides that hope.

Thank you for sharing your brave stories Chris and Brenda. ⁦⁦Canadian Cholangiocarcinoma Collaborative 🍁💚⁩ supports you and we urge the other provinces to join Quebec in giving patients access to pemigatinib. Please don’t deny these Canadian patients hope. #CCA #FGF2R calgary.ctvnews.ca/this-has-to-ch…

Congratulations to Dr. Rebecca Auer Rebecca Auer, MD on her new appointment at the The Ottawa Hospital! We are very proud to have Dr. Auer as a BioCanRx network investigator!

Great to be working with you NRC Canada on this important initiative!

A great start to the week with photos from Camille Leahy, patient advocate and CLIC1901 clinical trial participant representing Canada, BioCanRx, BCCA, TOH, OHRI at the 2024 Breakthrough Prize celebrating the 'Stars of Science' and Canadian Michel Sadelain. Félicitations!

Budget2024 is a big win for Canadian research. BioCanRx welcomes the announced new funding & key measures to boost research, innovation & productivity that will go a long way to driving Canadian discoveries from the bench to the bedside. canada.ca/en/department-… #CanadianResearch

Congratulations to the 24 recipients of funding through the Strategic Science Fund. For BioCanRx, the $38M over 5 years will allow us to continue to foster collaboration in cancer research & position Canada as a leader in the global fight to cure cancer. biocanrx.com/federal-invest…

Join us at the Westin Harbour Castle in Toronto in April, 2025 to explore the latest progress in cancer immunotherapy. Stay tuned as we prepare to announce more details and registration information in the coming weeks and months! #summit4CI #immunotherapy #cancerresearch

Had a great meeting last night with 13 advocates discussing ways to mobilize and participate in advocacy for cholangiocarcinoma! These meetings are co-hosted with Cholangio-Hepatocellularcarcinoma Canada + Cholangiocarcinoma Foundation and happen every 2nd Wednesday of the month. See you July 10!

Meet Camille Leahy , one of the brave individuals who have embarked on this experimental treatment alongside Dr. Michel Sadelain. Her story of courage and hope will inspire and move you, illustrating the profound impact of this therapy on real lives. livingdrugsmovie.com